V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20212053 | 20128582 | 1.87 | 73 | Palliative (P) | 2016-12-10 | 2016-12-17 | null | N | N | ECX | 100239610 |
| 20212059 | 20128584 | null | null | Curative (C) | 2018-05-12 | 2018-06-25 | null | 2 | N | CARBOPLATIN + ETOPOSIDE | 100101009 |
| 20212060 | 20128585 | 1.7 | 68.2 | Palliative (P) | 2020-02-11 | 2020-02-16 | null | N | null | CARBOPLATIN + ETOPOSIDE | 101315481 |
| 20212062 | 20128586 | 1.8 | null | Adjuvant (A) | 2016-08-03 | 2016-08-15 | ECX | N | N | ECX | 101362952 |
| 20212065 | 20128588 | 1.71 | 90.35 | Palliative (P) | 2018-04-03 | 2018-04-14 | null | N | N | ECX | 101713304 |
| 20212066 | 20128589 | 1.64 | 62 | Palliative (P) | 2019-01-29 | 2019-02-08 | null | 02 | N | CARBOPLATIN + ETOPOSIDE | 100932306 |
| 20212067 | 20128590 | 0 | 63.8 | Palliative (P) | 2016-04-14 | 2016-06-27 | Cisplatin +Fluorouracil (3 wk) | 2 | null | CISPLATIN + FLUOROURACIL | 101124124 |
| 20212068 | 20128591 | 1.65 | 83 | null | 2016-08-16 | 2016-08-19 | ECX | N | null | ECX | 100278402 |
| 20212069 | 20128592 | 1.65 | null | null | 2019-02-05 | 2019-02-20 | null | N | null | ECX | 100624876 |
| 20212070 | 20128593 | 1.71 | 63.5 | Palliative (P) | null | 2017-11-04 | Panitumumab | 2 | null | PANITUMUMAB | 101820944 |
| 20212073 | 20128595 | 1.67 | 59.7 | null | 2019-04-29 | 2019-05-31 | Carboplatin + Etoposide iv&po | 02 | null | CARBOPLATIN + ETOPOSIDE | 100394057 |
| 20212075 | 20128596 | 1.62 | 55 | null | 2020-03-24 | 2020-04-15 | ECX | N | N | ECX | 100766917 |
| 20212076 | 20128597 | 1.57 | 69.1 | Palliative (P) | 2016-03-09 | 2017-10-10 | null | N | N | ECX | 101466302 |
| 20212080 | 20128598 | 1.76 | 65 | null | 2020-05-03 | 2020-05-10 | null | N | Y | CISPLATIN + FLUOROURACIL | 100503967 |
| 20212081 | 20128599 | 1.78 | 66.9 | Neo-adjuvant (N) | 2019-05-11 | 2019-07-08 | Panitumumab | 02 | N | PANITUMUMAB | 100658239 |
| 20212083 | 20128601 | 1.65 | 81.6 | Adjuvant (A) | 2017-12-23 | 2018-01-08 | CISPLATIN + FLUOROURACIL | 2 | N | CISPLATIN + FLUOROURACIL | 100569767 |
| 20212092 | 20128604 | 1.77 | 58.55 | Curative (C) | 2017-01-04 | 2017-01-12 | CISPLATIN + FLUOROURACIL | N | N | CISPLATIN + FLUOROURACIL | 100248789 |
| 20212094 | 20128605 | null | null | null | 2018-06-15 | 2018-06-23 | Panitumumab | 02 | N | PANITUMUMAB | 100203168 |
| 20212096 | 20128606 | 1.66 | 78 | Neo-adjuvant (N) | 2019-12-01 | 2020-11-28 | CISPLATIN + FLUOROURACIL | 2 | N | CISPLATIN + FLUOROURACIL | 101645187 |
| 20212099 | 20128607 | 1.69 | 47.2 | Neo-adjuvant (N) | 2018-05-28 | 2018-06-08 | null | null | N | PANITUMUMAB | 100665394 |
| 20212101 | 20128608 | 1.6 | 81.6 | Neo-adjuvant (N) | 2021-10-08 | 2021-10-23 | null | 2 | N | NIVOLUMAB | 100100272 |
| 20212102 | 20128609 | 0 | 62 | Neo-adjuvant (N) | 2019-05-14 | 2020-07-03 | ECX | N | N | ECX | 100735373 |
| 20212105 | 20128611 | 1.53 | 62.8 | Neo-adjuvant (N) | 2018-10-16 | 2018-10-29 | Panitumumab | N | N | PANITUMUMAB | 101106195 |
| 20212106 | 20128612 | 1.73 | 93.5 | Adjuvant (A) | 2017-05-17 | 2017-05-22 | null | 02 | N | PANITUMUMAB | 100604540 |
| 20212112 | 20128615 | 1.63 | 47.2 | null | null | 2019-08-28 | NIVOLUMAB | N | N | NIVOLUMAB | 101525228 |
| 20212114 | 20128616 | 1.7 | null | Neo-adjuvant (N) | 2016-12-03 | 2016-12-03 | Carboplatin + Etoposide iv&po | 02 | N | CARBOPLATIN + ETOPOSIDE | 101239119 |
| 20212115 | 20128617 | 1.7 | 67 | Curative (C) | 2021-04-04 | 2021-04-12 | NIVOLUMAB | 2 | N | NIVOLUMAB | 100063132 |
| 20212116 | 20128618 | 0 | 114.8 | Palliative (P) | 2016-12-05 | 2016-12-14 | null | 02 | N | CARBOPLATIN + ETOPOSIDE | 100627340 |
| 20212117 | 20128619 | 1.56 | 59.1 | Palliative (P) | 2017-09-30 | 2017-10-18 | CARBOPLATIN + ETOPOSIDE | null | N | CARBOPLATIN + ETOPOSIDE | 100830628 |
| 20212124 | 20128623 | 1.57 | 74 | null | 2019-04-26 | 2019-05-08 | null | N | null | CARBOPLATIN + ETOPOSIDE | 101574246 |
| 20212125 | 20128624 | 1.6 | 64.15 | null | 2019-09-15 | 2019-09-18 | null | 02 | null | PANITUMUMAB | 100169953 |
| 20212126 | 20128625 | 1.65 | 64.8 | Neo-adjuvant (N) | 2017-11-22 | 2017-12-06 | Panitumumab | 02 | N | PANITUMUMAB | 101386554 |
| 20212127 | 20128626 | 1.6 | null | Neo-adjuvant (N) | 2016-10-22 | 2016-11-19 | null | N | N | ECX | 100531517 |
| 20212128 | 20128627 | null | 43 | null | 2019-07-18 | 2019-07-24 | null | null | null | CARBOPLATIN + ETOPOSIDE | 101798688 |
| 20212129 | 20128628 | null | null | Neo-adjuvant (N) | 2018-06-03 | 2018-06-03 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100195871 |
| 20212130 | 20128629 | 1.72 | 80 | Neo-adjuvant (N) | null | 2017-04-06 | ECX | 02 | N | ECX | 100812351 |
| 20212131 | 20128630 | 1.81 | 69.3 | Adjuvant (A) | 2020-01-10 | 2020-01-18 | CARBOPLATIN + ETOPOSIDE | null | N | CARBOPLATIN + ETOPOSIDE | 101512552 |
| 20212134 | 20128631 | 1.87 | 79.9 | Neo-adjuvant (N) | 2018-03-01 | 2018-08-13 | null | 02 | N | CARBOPLATIN + ETOPOSIDE | 101020470 |
| 20212135 | 20128632 | 1.78 | 94.76 | Adjuvant (A) | 2021-02-24 | 2021-03-03 | null | N | Y | ECX | 100936534 |
| 20212141 | 20128633 | 1.77 | null | Palliative (P) | null | 2019-04-17 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100257304 |
| 20212142 | 20128634 | 1.71 | 92.7 | Adjuvant (A) | 2016-12-21 | 2016-12-21 | NIVOLUMAB | N | N | NIVOLUMAB | 101371392 |
| 20212145 | 20128637 | 1.79 | null | null | 2018-04-27 | 2018-05-04 | null | N | null | ECX | 101475422 |
| 20212146 | 20128638 | 1.72 | 43.5 | Palliative (P) | null | 2017-08-29 | ECX | N | N | ECX | 100170397 |
| 20212148 | 20128639 | 1.71 | 107 | Palliative (P) | 2017-11-22 | 2017-11-29 | Panitumumab | 02 | N | PANITUMUMAB | 101389036 |
| 20212150 | 20128640 | 1.81 | 99.6 | Curative (C) | 2018-09-28 | 2018-10-19 | null | N | N | PANITUMUMAB | 100599325 |
| 20212153 | 20128641 | 1.75 | 61.5 | Palliative (P) | 2020-04-19 | 2020-05-08 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101829390 |
| 20212157 | 20128642 | 1.66 | null | Adjuvant (A) | 2017-12-17 | 2018-06-13 | null | N | Y | ECX | 101281213 |
| 20212158 | 20128643 | 1.73 | null | Palliative (P) | 2019-04-10 | 2019-04-13 | null | 02 | N | CARBOPLATIN + ETOPOSIDE | 101611424 |
| 20212159 | 20128644 | 1.72 | null | Neo-adjuvant (N) | 2018-03-20 | 2018-04-11 | Panitumumab | N | N | PANITUMUMAB | 100016305 |
| 20212160 | 20128645 | 1.65 | 72 | Palliative (P) | 2020-01-03 | 2020-08-19 | CARBOPLATIN + ETOPOSIDE | 02 | N | CARBOPLATIN + ETOPOSIDE | 101431698 |